A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
XenonSevofluraneAnesthetics, InhalationCoronary DiseaseCoronary Artery Bypass
Interventions
DRUG

Xenon

gaseous anesthetic, dosage: 50% (v/v) in 50% oxygen, continuous application before the start and after the end of extracorporal circulation

DRUG

Sevoflurane

inhalative anesthetic, dosage: 1.4% (v/v) in 50% oxygen/medical air , continuous application before the start and after the end of extracorporal circulation

Trial Locations (1)

52074

Department of Anesthesiology, University Hospital Aachen, Aachen

Sponsors
All Listed Sponsors
collaborator

German Research Foundation

OTHER

lead

RWTH Aachen University

OTHER